A Double Blind, Parallel-group, Randomized Placebo Controlled, Multicentre Exploratory Study of Dimiracetam in Treatment Induced Painful Neuropathy in Patients With HIV Infection.

Trial Profile

A Double Blind, Parallel-group, Randomized Placebo Controlled, Multicentre Exploratory Study of Dimiracetam in Treatment Induced Painful Neuropathy in Patients With HIV Infection.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Aug 2011

At a glance

  • Drugs Dimiracetam (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Aug 2011 New trial record
    • 21 Oct 2010 Interim results were reported in a Neurotune Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top